Last reviewed · How we verify
Upper respiratory infection
Approved treatments
- Cefradex · Bristol-Myers Squibb
- Penicillin G Potassium In Plastic Container · Pfizer
- Ceclor
- Cefzil · Teva Pharmaceuticals USA
- Suprax
Suprax works by inhibiting the bacterial enzyme 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, disrupting bacterial cell wall synthesis. - Cephradin · Sohag University
- penicillin · Karlstad University
- Phenoxymethylpenicillin · Katarina Hedin
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Upper respiratory infection patent landscape — cliff calendar, originator estates, attackable patents
- Upper respiratory infection treatment landscape brief
- Upper respiratory infection treatment updates RSS
Frequently asked questions about Upper respiratory infection
What drugs treat Upper respiratory infection?
Tracked treatments include Cefradex, Penicillin G Potassium In Plastic Container, Ceclor, Cefzil, Suprax, Cephradin, penicillin, Phenoxymethylpenicillin.
What is the treatment for Upper respiratory infection?
Standard treatment for Upper respiratory infection includes Cefradex, Penicillin G Potassium In Plastic Container, Ceclor, Cefzil, Suprax. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Upper respiratory infection patent cliff · Upper respiratory infection CI report
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Ceclor
- Treatment: Cefzil · Teva Pharmaceuticals USA
- Treatment: Suprax
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing